Literature DB >> 23343515

Selective in vivo visualization of immune-cell infiltration in a mouse model of autoimmune myocarditis by fluorine-19 cardiac magnetic resonance.

Ruud B van Heeswijk1, Jonathan De Blois, Gabriela Kania, Christine Gonzales, Przemyslaw Blyszczuk, Matthias Stuber, Urs Eriksson, Juerg Schwitter.   

Abstract

BACKGROUND: The goal of this study was to characterize the performance of fluorine-19 ((19)F) cardiac magnetic resonance (CMR) for the specific detection of inflammatory cells in a mouse model of myocarditis. Intravenously administered perfluorocarbons are taken up by infiltrating inflammatory cells and can be detected by (19)F-CMR. (19)F-labeled cells should, therefore, generate an exclusive signal at the inflamed regions within the myocardium. METHODS AND
RESULTS: Experimental autoimmune myocarditis was induced in BALB/c mice. After intravenous injection of 2×200 µL of a perfluorocarbon on day 19 and 20 (n=9) after immunization, in vivo (19)F-CMR was performed at the peak of myocardial inflammation (day 21). In 5 additional animals, perfluorocarbon combined with FITC (fluorescein isothiocyanate) was administered for postmortem immunofluorescence and flow-cytometry analyses. Control experiments were performed in 9 animals. In vivo (19)F-CMR detected myocardial inflammation in all experimental autoimmune myocarditis-positive animals. Its resolution was sufficient to identify even small inflammatory foci, that is, at the surface of the right ventricle. Postmortem immunohistochemistry and flow cytometry confirmed the presence of perfluorocarbon in macrophages, dendritic cells, and granulocytes, but not in lymphocytes. The myocardial volume of elevated (19)F signal (rs=0.96; P<0.001), the (19)F signal-to-noise ratio (rs=0.92; P<0.001), and the (19)F signal integral (rs=0.96; P<0.001) at day 21 correlated with the histological myocarditis severity score.
CONCLUSIONS: In vivo (19)F-CMR was successfully used to visualize the inflammation specifically and robustly in experimental autoimmune myocarditis, and thus allowed for an unprecedented insight into the involvement of inflammatory cells in the disease process.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23343515     DOI: 10.1161/CIRCIMAGING.112.000125

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN: 1941-9651            Impact factor:   7.792


  21 in total

1.  Silencing of CCR2 in myocarditis.

Authors:  Florian Leuschner; Gabriel Courties; Partha Dutta; Luke J Mortensen; Rostic Gorbatov; Brena Sena; Tatiana I Novobrantseva; Anna Borodovsky; Kevin Fitzgerald; Victor Koteliansky; Yoshiko Iwamoto; Marina Bohlender; Soeren Meyer; Felix Lasitschka; Benjamin Meder; Hugo A Katus; Charles Lin; Peter Libby; Filip K Swirski; Daniel G Anderson; Ralph Weissleder; Matthias Nahrendorf
Journal:  Eur Heart J       Date:  2014-06-20       Impact factor: 29.983

2.  Cell tracking using (19)F magnetic resonance imaging: technical aspects and challenges towards clinical applications.

Authors:  Houshang Amiri; Mangala Srinivas; Andor Veltien; Mark J van Uden; I Jolanda M de Vries; Arend Heerschap
Journal:  Eur Radiol       Date:  2014-11-06       Impact factor: 5.315

3.  Nano-scale treatment for a macro-scale disease: nanoparticle-delivered siRNA silences CCR2 and treats myocarditis.

Authors:  Leslie T Cooper; DeLisa Fairweather
Journal:  Eur Heart J       Date:  2014-08-24       Impact factor: 29.983

4.  Sex differences in translocator protein 18 kDa (TSPO) in the heart: implications for imaging myocardial inflammation.

Authors:  DeLisa Fairweather; Michael J Coronado; Amanda E Garton; Jennifer L Dziedzic; Adriana Bucek; Leslie T Cooper; Jessica E Brandt; Fatima S Alikhan; Haofan Wang; Christopher J Endres; Judy Choi; Martin G Pomper; Tomás R Guilarte
Journal:  J Cardiovasc Transl Res       Date:  2014-01-09       Impact factor: 4.132

5.  Epicardium-Derived Cells Formed After Myocardial Injury Display Phagocytic Activity Permitting In Vivo Labeling and Tracking.

Authors:  Zhaoping Ding; Sebastian Temme; Christine Quast; Daniela Friebe; Christoph Jacoby; Klaus Zanger; Hans-Jürgen Bidmon; Christoph Grapentin; Rolf Schubert; Ulrich Flögel; Jürgen Schrader
Journal:  Stem Cells Transl Med       Date:  2016-04-07       Impact factor: 6.940

6.  Visualization of immune cell infiltration in experimental viral myocarditis by (19)F MRI in vivo.

Authors:  Christoph Jacoby; Nadine Borg; Philipp Heusch; Martina Sauter; Florian Bönner; Reinhard Kandolf; Karin Klingel; Jürgen Schrader; Ulrich Flögel
Journal:  MAGMA       Date:  2013-07-04       Impact factor: 2.310

7.  Carvedilol improves biventricular fibrosis and function in experimental pulmonary hypertension.

Authors:  Kenichi Okumura; Hideyuki Kato; Osami Honjo; Siegfried Breitling; Wolfgang M Kuebler; Mei Sun; Mark K Friedberg
Journal:  J Mol Med (Berl)       Date:  2015-01-18       Impact factor: 4.599

Review 8.  Nanotechnology as a Versatile Tool for 19F-MRI Agent's Formulation: A Glimpse into the Use of Perfluorinated and Fluorinated Compounds in Nanoparticles.

Authors:  Joice Maria Joseph; Maria Rosa Gigliobianco; Bita Mahdavi Firouzabadi; Roberta Censi; Piera Di Martino
Journal:  Pharmaceutics       Date:  2022-02-09       Impact factor: 6.321

9.  Chemical shift encoding (CSE) for sensitive fluorine-19 MRI of perfluorocarbons with complex spectra.

Authors:  Ruud B van Heeswijk; Roberto Colotti; Emeline Darçot; Jean Delacoste; Maxime Pellegrin; Davide Piccini; Diego Hernando
Journal:  Magn Reson Med       Date:  2017-09-01       Impact factor: 4.668

10.  We see only what we look for: imaging cardiac inflammation.

Authors:  Leslie T Cooper; DeLisa Fairweather
Journal:  Circ Cardiovasc Imaging       Date:  2013-03-01       Impact factor: 7.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.